CN1883580A - Chinese medicine compound preparation - Google Patents
Chinese medicine compound preparation Download PDFInfo
- Publication number
- CN1883580A CN1883580A CNA2006100317267A CN200610031726A CN1883580A CN 1883580 A CN1883580 A CN 1883580A CN A2006100317267 A CNA2006100317267 A CN A2006100317267A CN 200610031726 A CN200610031726 A CN 200610031726A CN 1883580 A CN1883580 A CN 1883580A
- Authority
- CN
- China
- Prior art keywords
- radix
- salviae miltiorrhizae
- semen persicae
- cortex eucommiae
- flos carthami
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims description 14
- 241000628997 Flos Species 0.000 claims description 25
- 210000000582 semen Anatomy 0.000 claims description 23
- 241000180649 Panax notoginseng Species 0.000 claims description 22
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 22
- 235000013399 edible fruits Nutrition 0.000 claims description 20
- 239000000470 constituent Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 3
- 241000190633 Cordyceps Species 0.000 claims description 3
- 241000237903 Hirudo Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 241000522620 Scorpio Species 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 239000009490 scorpio Substances 0.000 claims description 3
- 206010003119 arrhythmia Diseases 0.000 abstract description 12
- 230000006793 arrhythmia Effects 0.000 abstract description 12
- 208000029078 coronary artery disease Diseases 0.000 abstract description 12
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 11
- 208000002173 dizziness Diseases 0.000 abstract description 11
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 10
- 206010019233 Headaches Diseases 0.000 abstract description 10
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 10
- 231100000869 headache Toxicity 0.000 abstract description 10
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract description 9
- 230000002792 vascular Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 5
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000425037 Toona sinensis Species 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000000341 volatile oil Substances 0.000 description 19
- 239000002775 capsule Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 17
- 239000000843 powder Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 238000003306 harvesting Methods 0.000 description 10
- 235000008216 herbs Nutrition 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 239000008187 granular material Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000015091 medicinal tea Nutrition 0.000 description 7
- 229920000858 Cyclodextrin Polymers 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- YQNGUUQYDSHYMO-MVAXXSNXSA-N 5-hydroxy-4-[(e)-3-(4-hydroxyphenyl)prop-2-enoyl]-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexa-3,5-diene-1,2-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(C(=O)C=C1O)=O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 YQNGUUQYDSHYMO-MVAXXSNXSA-N 0.000 description 1
- 108010007828 Allantoinase Proteins 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- SBAFZBVZGFUKPK-MVAXXSNXSA-N Carthamone Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(C(O)=CC1=O)=O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 SBAFZBVZGFUKPK-MVAXXSNXSA-N 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000158723 Melia Species 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000001407 Vascular Headaches Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- -1 methane series saponin Chemical class 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal compound preparation, which comprises the following components and dosage (by weight percent): 10-80% of Chinese toon, 1-30% of safflower, 1-30% of peach kernel, 2-50% of pseudo-ginseng, 2-50% of salvia miltiorrhiza and 1-20% of eucommia bark. The preparation is pharmaceutically and edible, and can be used as food for preventing coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness and headache, and for treating coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness and headache.
Description
Technical field
The invention belongs to Chinese medicine, being specifically related to is the compound Chinese medicinal preparation of a kind of prevention, treatment coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular headache dizziness.
Background technology
Along with society's continuous development forward, human living standard progressively improves, and the nutrient substance of absorption is increasing, and the prevalence of modern's hyperlipidemia, hypertension, arteriosclerosis, arrhythmia, coronary heart disease etc. is more and more higher.At present, the Chinese medicine that is used for the treatment of this class cardiovascular diseases all be with medicinal Chinese crude drug as medicinal component, be primarily aimed at disease itself and play therapeutical effect, its function is more single, can only be as medicinal.
Technology contents
The purpose of this invention is to provide a kind of not only pharmaceutically acceptable but also edible compound Chinese medicinal preparation.Said preparation can be used as the food of prevention coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headache at ordinary times and takes, and also can have therapeutical effect to diseases such as coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headaches.
In order to realize order of the present invention, compound Chinese medicinal preparation of the present invention adopts and comprises that with Tonnae Sinensis (tender leaf or fruit), Flos Carthami, Semen Persicae, Radix Notoginseng, Radix Salviae Miltiorrhizae, the Cortex Eucommiae etc. be the crude drug of key component, is used for diseases such as prevention or treatment coronary disease pain, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headache.Tonnae Sinensis is the perennial arbor of Meliaceae Melia, but also is a kind of a kind of especially good to eat delicious food of plant, especially Tonnae Sinensis tender leaf of very common edible medicine, the Tonnae Sinensis fruit in traditional medicine as medicinal.Traditional medicine think Folium toonae sinensis, Tonnae Sinensis fruit (son) function cure mainly dispel the wind, cold expelling, pain relieving, circulation of qi promoting, can be used for treating anemofrigid cold, the thoracic obstruction, uncomfortable in chest, dizziness headache etc.; Flos Carthami is a kind of Chinese medicine commonly used, has the effect of blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia; Semen Persicae has blood circulation promoting and blood stasis dispelling, moisturizes the effect of intestine moistening; Radix Notoginseng has the effect of hemostasis dissipating blood stasis, subduing swelling and relieving pain; Radix Salviae Miltiorrhizae has stasis-dispelling and pain-killing, promoting blood flow to regulate menstruation, the effect of the relieving restlessness of nourishing heart; The effect of Cortex Eucommiae invigorating the liver and kidney, bone and muscle strengthening, antiabortive, blood pressure lowering.Modern study shows volatile oil such as containing elemene in the Tonnae Sinensis (tender leaf or fruit) and abundant vitamin and mineral; Contain saffloside, carthamone and neocarthamin in the Flos Carthami; Contain amygdaloside, emulsin, allantoinase, Lactose enzyme, vitamin, fatty wet goods in the Semen Persicae; Contain multiple saponin in the Radix Notoginseng, main for agate fat methane series saponin, also contain styptic activity composition dencichine and a small amount of flavonoid glycoside etc.; Mainly contain Tanshinone I, Tanshinone I I, cryptotanshinone, carnosol, protocatechualdehyde, Radix Salviae Miltiorrhizae acid etc. in the Radix Salviae Miltiorrhizae; Contain aucubin, gutta-percha, pectin, chlorogenic acid, vitamin etc. in the Cortex Eucommiae.Dialectical opinion according to Chinese medical theory is controlled and reasonable compatibility, through clinic trial, the present invention is based on Tonnae Sinensis (tender leaf or fruit), and the compatibility other drug has good effect to preventing or treating diseases such as coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headache.
In order to reach better prevention or therapeutic effect, compound Chinese medicinal preparation of the present invention can also contain accessory constituent, and described accessory constituent comprises and is selected from the following crude drug one or more: the Cordyceps of invigorating the lung and the kidney, the Radix Panacis Quinquefolii of boosting qi and nourishing yin clearing away heat and promoting production of body fluid, the Radix Ginseng of strongly invigorating primordial QI invigorating the spleen to benefit the lung, the Radix Pseudostellariae of replenishing QI to invigorate the spleen promoting the production of body fluid for nourishing the lung, the Radix Astragali of invigorating QI to consolidate the body surface resistance diuresis poison holding, the promoting blood flow to regulate menstruation analgesic Radix Angelicae Sinensis of enriching blood, the Rhizoma Gastrodiae of suppressing the hyperactive liver to relieve the wind syndrome relieving convulsion, the Ramulus Cinnamomi of the supporing yang activating QI of warming the meridian and promoting blood circulation, expelling pathogenic factors from muscles for reducing heat yang invigorating antidiarrheal Radix Puerariae, the Fructus Lycii that nourishing the liver and kidney benefit Tianjin makes eye bright, the Fructus Schisandrae Chinensis of supplementing QI for promoting the production of body fluid kidney calming, the Ramulus Uncariae Cum Uncis of heat clearing away suppressing the hyperactive liver to relieve the wind syndrome arresting convulsion, the Bulbus Allii Macrostemonis of activating YANG and eliminating stagnation circulation of qi promoting intestinal stasis relieving, the Radix Rehmanniae of clearing away heat and promoting production of body fluid cooling blood for hemostasis, the Flos Chrysanthemi that the wind heat clearing away suppressing the hyperactive liver that looses makes eye bright, the Pericarpium Citri Reticulatae of regulating qi-flowing for strengthening spleen drying dampness to eliminate phlegm, the Rhizoma Chuanxiong of blood-activating and qi-promoting wind-expelling pain-stopping, the Scorpio of endogenous wind stopping spasmolytic removing obstruction in the collateral to relieve pain, the Hirudo of eliminating blood stasis and inducing menstruation, the Zaocys of dispelling wind and removing obstruction in the collateral relieving convulsion etc.
Tonnae Sinensis is a kind of good to eat delicious food commonly used, among the peoplely commonly uses.Flos Carthami, Semen Persicae, Radix Notoginseng, Radix Salviae Miltiorrhizae, the Cortex Eucommiae are the kinds in the medicine-food two-purpose catalogue of Ministry of Public Health promulgation.So the present invention can be used as the food of prevention coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headache and takes for a long time.And according to Chinese medical theory and practical clinical, the present invention has therapeutical effect to diseases such as coronary heart disease, arrhythmia, arteriosclerosis, hyperlipidemia, hypercholesterolemia, vascular dizziness headaches.
The consumption of each component of compound Chinese medicinal preparation of the present invention (by weight percentage) scope is:
Tonnae Sinensis (tender leaf or fruit etc.) 10～80%, Flos Carthami 1～30%, Semen Persicae 1～30%, Radix Notoginseng 2～50%, Radix Salviae Miltiorrhizae 2～50%, the Cortex Eucommiae 1～20%.
Be preferably: Tonnae Sinensis (tender leaf or fruit etc.) 60%, Flos Carthami 5%, Semen Persicae 5%, Radix Notoginseng 10%, Radix Salviae Miltiorrhizae 10%, the Cortex Eucommiae 10%.
In the compound Chinese medicinal preparation of the present invention the consumption of each component (by weight percentage) scope can also for:
Tonnae Sinensis (tender leaf or fruit etc.) 10～70%, Flos Carthami 1～25%, Semen Persicae 1～25%, Radix Notoginseng 2～40%, Radix Salviae Miltiorrhizae 2～40%, the Cortex Eucommiae 1～20%, accessory constituent 5～30%.
Be preferably: Tonnae Sinensis (tender leaf or fruit etc.) 55%, Flos Carthami 5%, Semen Persicae 5%, Radix Notoginseng 8%, Radix Salviae Miltiorrhizae 8%, the Cortex Eucommiae 8%, accessory constituent 11%.
Combination drug of the present invention can adopt the Chinese medicine preparation conventional method to make various oral, injections, external preparation uses for different crowds.
The present invention is by the following example and the in addition clearer and more definite explanation of experiment.But, be interpreted as the restriction that the present invention is subjected to these examples never in any form.
The specific embodiment
Embodiment 1:
Tonnae Sinensis is the Meliaceae plant, and its tender leaf or Tonnae Sinensis fruit are after harvesting, and drying in the air about 1～4 hour at room temperature shady and cool place, gets dried feed 10%, pulverizes; Get Flos Carthami 30%, Semen Persicae 1%, Radix Notoginseng 50%, Radix Salviae Miltiorrhizae 2%, the Cortex Eucommiae 7% five kinds of Chinese medicine, pulverize; With above-mentioned medicated powder mix homogeneously, can be packaged into oral formulations commonly used such as capsule, teabag or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 2:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, and drying in the air about 1～4 hour at room temperature shady and cool place, gets dried feed 10%, smashes; Add 8～10 times of water, the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 1.35 that the water extract is concentrated into proportion.Flos Carthami 1%, Radix Notoginseng 8%, Semen Persicae 30%, Radix Salviae Miltiorrhizae 50%, the Cortex Eucommiae 1% five tastes are pulverized.With above-mentioned medicated powder and Tonnae Sinensis water extract mix homogeneously, granulation, drying, add Tonnae Sinensis volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 3:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, and drying in the air about 1～4 hour at room temperature shady and cool place, gets dried feed 80%, smashes; 1% Semen Persicae, 14% Cortex Eucommiae powder are broken into coarse powder; Above-mentioned three flavors add 8～10 times of water, and the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 1.35 that the water extract is concentrated into proportion.1% Flos Carthami, 2% Radix Notoginseng, 2% Radix Salviae Miltiorrhizae, three flavors are pulverized.With above-mentioned medicated powder and water extract mix homogeneously granulate, drying, add Tonnae Sinensis volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 4:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 50% smashes; 5% Semen Persicae, 20% Cortex Eucommiae powder are broken into coarse powder; Above-mentioned three flavors add 8～10 times of water, and the heating extraction secondary is collected behind volatile oil cold preservation or the enclose standby simultaneously; It is about 1.20 that the water extract is concentrated into proportion, adds ethanol and makes that to contain the alcohol amount be about 50%, precipitate 12～48 hours, filtration, and filtrate continuation is concentrated into 1.20～1.40, and is standby.5% Flos Carthami, 10% Radix Notoginseng, 10% Radix Salviae Miltiorrhizae, three flavors are pulverized, and with the ethanol extraction of 5～10 times of amounts 60～95% 2～10 hours, filtration is concentrated into 1.20～1.40, and was standby.After said extracted thing vacuum drying or the spray drying, add volatile oil or its clathrate, appropriate amount of auxiliary materials, granulate, behind the mix homogeneously, tablet made by tabletting, coating or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 5:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 60% smashes; Are ground into 5% Semen Persicae, 10% second month in a season coarse powder; Above-mentioned three flavors add 8～10 times of water, and the heating extraction secondary is collected behind volatile oil cold preservation or the enclose standby simultaneously; It is about 1.20 that the water extract is concentrated into proportion, adds ethanol and makes that to contain the alcohol amount be 50%, precipitate 12～48 hours, filters, and filtrate continuation is concentrated into 120～1.40, add 2 times of water again and leave standstill, and filtration, cryoconcentration, cold drying, standby.5% Flos Carthami, 10% Radix Notoginseng, 10% Radix Salviae Miltiorrhizae, three flavors are pulverized, and with the ethanol extraction of 5～10 times of amounts 60～95% 2～10 hours, filter, and are concentrated into 1.20～1.40, and add ethanol and leave standstill, filtration, cryoconcentration, cold drying is standby.Taking polyethylene glycol melts in right amount, above-mentioned volatile oil, extract is added in the Polyethylene Glycol that melts mix homogeneously, splash into again to coolant, make drop pill, also above-mentioned volatile oil, extract can be added an amount of microcrystalline Cellulose and analog, make pellet.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 6:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 60% smashes; 5% Semen Persicae, 10～Cortex Eucommiae powder are broken into coarse powder; Above-mentioned three flavors add 8～10 times of water, and the heating extraction secondary is collected volatile oil cold preservation (A) simultaneously; It is about 1.20 that the water extract is concentrated into proportion, adds ethanol and makes that to contain the alcohol amount be more than 50%, precipitate 12～48 hours, filters, and filtrate continuation is concentrated into 120～1.40, adds 2 times of water again and leaves standstill, filtration, cryopreservation standby (B).5% Flos Carthami, 10% Radix Notoginseng, 10% Radix Salviae Miltiorrhizae, three flavors, pulverize, with 5～10 times of amount ethanol extractions of 60～95% 2～10 hours, filter, be concentrated into 1.20～1.40, adding ethanol leaves standstill, filter cryoconcentration, cold drying, add injection Oleum Arachidis hypogaeae semen or the analog and 1 times of amount lecithin or analog of 5 times of amounts, grinding makes homogenize standby (C).Under low temperature state, continue to grind the C component, slowly add the A component simultaneously, the last B component that slowly adds continued to homogenize 1 hour, and injection is made in fill.Dosage is counted with raw medicinal herbs: once-a-day, and each 4.5～12 grams, but life-time service.
Embodiment 7:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 74% smashes, and Ramulus Cinnamomi 2% is cut little disconnected, adds 8～10 times of water, and the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 1.35 that the water extract is concentrated into proportion.Flos Carthami 2%, Radix Notoginseng 7%, Semen Persicae 2%, Radix Salviae Miltiorrhizae 7%, the Cortex Eucommiae 2%, Cordyceps 1%) Radix Panacis Quinquefolii 2%, Rhizoma Gastrodiae 1% 8 flavor, pulverize.With above-mentioned medicated powder and Tonnae Sinensis, Ramulus Cinnamomi extract mix homogeneously, granulation, drying, add volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 8:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 30% smashes, and Pericarpium Citri Reticulatae 5% shredding adds 8～10 times of water, and the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 1.35 that the water extract is concentrated into proportion.Flos Carthami 2%, Radix Notoginseng 7%, Semen Persicae 2%, Radix Salviae Miltiorrhizae 20%, the Cortex Eucommiae 12%, the Radix Astragali 5%, Radix Pseudostellariae 8%, Ramulus Uncariae Cum Uncis 5%, Radix Rehmanniae 4% 9 flavor, dry, pulverizing.With above-mentioned medicated powder and Tonnae Sinensis, Pericarpium Citri Reticulatae extract mix homogeneously, granulation, drying, add volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 9:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 55% smashes, and Ramulus Cinnamomi 1% is cut little disconnected, and Bulbus Allii Macrostemonis 1% smashes, and adds 8～10 times of water, and the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 1.35 that the water extract is concentrated into proportion.Flos Carthami 5%, Radix Notoginseng 8%, Semen Persicae 5%, Radix Salviae Miltiorrhizae 8%, the Cortex Eucommiae 8%, Radix Ginseng 1%, Radix Puerariae 3%, Flos Chrysanthemi 5% 8 flavor are pulverized.Above-mentioned medicated powder is mixed evenly with extracts such as Tonnae Sinensis, Ramulus Cinnamomi, granulation, drying, add volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams can be taken for a long time.
Embodiment 10:
Tonnae Sinensis (tender leaf or fruit) is after harvesting, dries in the air about 1～4 hour at room temperature shady and cool place, and dried feed 30% smashes, and Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 3% shave add 8～10 times of water, and the heating extraction secondary is collected volatile oil or simultaneously with standby behind the cyclodextrin inclusion compound; It is about 135 that the water extract is concentrated into proportion.Flos Carthami 6%, Radix Notoginseng 7%, Semen Persicae 2%, Radix Salviae Miltiorrhizae 16%, the Cortex Eucommiae 6%, Rhizoma Gastrodiae 6%, Fructus Lycii 8%, Fructus Schisandrae Chinensis 2%, Scorpio 2%, Hirudo 2%, Zaocys 5%0 are pulverized simply.Above-mentioned medicated powder is mixed evenly with extracts such as Tonnae Sinensis, Radix Angelicae Sinensis, granulation, drying, add volatile oil clathrate compound and proper auxiliary materials, mix homogeneously, tabletting, coating make tablet or capsule charge is made capsule or pouch-packaged is made oral formulations commonly used such as granule, medicinal tea or external application medicated bag etc.Oral dose is counted with raw medicinal herbs: three times on the one, each 1.5～3.0 grams, this embodiment are mainly used in hyperlipidemia, sclerosis of blood vessels is seen treatment of apoplexy sequela and prevention Secondary cases apoplexy.
Experimental example 1:
Xiao, the man 52 years old now, because of boiler room work is arranged for a long time, suffers from the arrhythmia coronary heart disease several years in the time of 43 years old.Capsule through taking embodiment 1 removed examination in hospital after three months, and arrhythmia coronary heart disease is cured.After adhere to taking, existing Xiao is in the best of spirit, and is glowing with health.
Experimental example 2:
Deng, the man, 61 years old now, several years ago suffer from sclerosis of blood vessels, higher, the hypertension of blood fat, through take the capsule of embodiment 2 throughout the year, every index has all been recovered normally, and the mental status is good.
Experimental example 3:
Liu, the man, 71 years old now, old patients with gastric disease, dizziness headache, half body symptom such as itch often appears in hypertension in recent years, cerebrovascular sclerosis, take the capsule two weeks of the embodiment of the invention 1 after, promptly have clear improvement, now just adhering to taking.
Claims (4)
1, a kind of compound Chinese medicinal preparation is characterized in that comprising following component and consumption (by weight percentage): Tonnae Sinensis 10～80%, Flos Carthami 1～30%, Semen Persicae 1～30%, Radix Notoginseng 2～50%, Radix Salviae Miltiorrhizae 2～50%, the Cortex Eucommiae 1～20%.
2, compound Chinese medicinal preparation according to claim 1 is characterized in that the consumption of each component is: Tonnae Sinensis (tender leaf or fruit etc.) 60%, Flos Carthami 5%, Semen Persicae 5%, Radix Notoginseng 10%, Radix Salviae Miltiorrhizae 10%, the Cortex Eucommiae 10%.
3, a kind of compound Chinese medicinal preparation is characterized in that comprising following component and consumption (by weight percentage): Tonnae Sinensis 10～70%, Flos Carthami 1～25%, Semen Persicae 1～25%, Radix Notoginseng 2～40%, Radix Salviae Miltiorrhizae 2～40%, the Cortex Eucommiae 1～20%, accessory constituent 5～30%.
Wherein accessory constituent comprises and is selected from the following crude drug one or more: Cordyceps, Radix Panacis Quinquefolii, Radix Ginseng, Radix Pseudostellariae, the Radix Astragali, Radix Angelicae Sinensis, Rhizoma Gastrodiae, Ramulus Cinnamomi, Radix Puerariae, Fructus Lycii, Fructus Schisandrae Chinensis, Ramulus Uncariae Cum Uncis, Bulbus Allii Macrostemonis, Radix Rehmanniae, Flos Chrysanthemi, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong, Scorpio, Hirudo, Zaocys.
4, compound Chinese medicinal preparation according to claim 3 is characterized in that the consumption of each component is: Tonnae Sinensis 55%, Flos Carthami 5%, Semen Persicae 5%, Radix Notoginseng 8%, Radix Salviae Miltiorrhizae 8%, the Cortex Eucommiae 8%, accessory constituent 11%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100317267A CN100518765C (en) | 2006-05-30 | 2006-05-30 | A compound Chinese medicinal preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100317267A CN100518765C (en) | 2006-05-30 | 2006-05-30 | A compound Chinese medicinal preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1883580A true CN1883580A (en) | 2006-12-27 |
| CN100518765C CN100518765C (en) | 2009-07-29 |
Family
ID=37581962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100317267A Expired - Fee Related CN100518765C (en) | 2006-05-30 | 2006-05-30 | A compound Chinese medicinal preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100518765C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306633A (en) * | 2014-09-27 | 2015-01-28 | 徐玉文 | A traditional Chinese medicine for treating headache due to stagnation of phlegm |
| CN105616491A (en) * | 2016-03-10 | 2016-06-01 | 刘建存 | Traditional Chinese medicine combination capable of lowering blood pressure auxiliarily for coronary heart disease therapy and preparation method of combination |
| CN106491958A (en) * | 2015-09-08 | 2017-03-15 | 上海中医药大学附属曙光医院 | Compound Chinese medicinal preparation for the treatment of coronary disease and angina pectoris and preparation method thereof |
| CN109248274A (en) * | 2018-11-19 | 2019-01-22 | 青海师范大学 | A kind of Tibetan medicinal composition and its application in medicine preparation |
-
2006
- 2006-05-30 CN CNB2006100317267A patent/CN100518765C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306633A (en) * | 2014-09-27 | 2015-01-28 | 徐玉文 | A traditional Chinese medicine for treating headache due to stagnation of phlegm |
| CN106491958A (en) * | 2015-09-08 | 2017-03-15 | 上海中医药大学附属曙光医院 | Compound Chinese medicinal preparation for the treatment of coronary disease and angina pectoris and preparation method thereof |
| CN105616491A (en) * | 2016-03-10 | 2016-06-01 | 刘建存 | Traditional Chinese medicine combination capable of lowering blood pressure auxiliarily for coronary heart disease therapy and preparation method of combination |
| CN109248274A (en) * | 2018-11-19 | 2019-01-22 | 青海师范大学 | A kind of Tibetan medicinal composition and its application in medicine preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100518765C (en) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102228485B (en) | Composition for burn rehabilitation and preparation method thereof | |
| CN102860395A (en) | Natural herbal tea and preparation method thereof | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN100518765C (en) | A compound Chinese medicinal preparation | |
| CN114010709A (en) | External traditional Chinese medicine ointment for treating myopia and preparation method thereof | |
| CN1263503C (en) | 'Changyuan' capsule and preparing techniue | |
| CN111617172A (en) | A topical Chinese medicinal composition and its preparation method | |
| CN101933973A (en) | Medicament composition for preventing and treating liver damage | |
| CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
| CN105343660A (en) | Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation | |
| CN103751547A (en) | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof | |
| CN101112498B (en) | Chinese traditional medicine having functions of promoting blood circulation, relaxing vein and strengthening muscles and bones and method for preparing the same | |
| CN110215485B (en) | Traditional Chinese medicine composition for treating diabetic skin ulcer and preparation method thereof | |
| CN102397470A (en) | Beautifying spot-removing cream and preparation method thereof | |
| CN102626471B (en) | Traditional Chinese medicine composition with effects of anti-anaphylaxis, desensitization, repair and regeneration | |
| CN105561098A (en) | Medicine for treating erosive beriberi | |
| CN105853866A (en) | Method for preparing Chinese herbal medicine composition for treating bedsore | |
| CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
| CN1234388C (en) | External-use medicinal composition for treating gall | |
| CN111568986B (en) | Chinese medicinal oral prescription for setting fracture, external ointment and preparation method thereof | |
| CN115120634B (en) | Traditional Chinese medicine compound preparation for preventing and treating alcoholic liver injury and preparation method and application thereof | |
| CN114848764B (en) | Traditional Chinese medicine compound composition for preventing and treating liver injury and preparation method and application thereof | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN102178813A (en) | Slimming beauty scraping oil and preparation method thereof | |
| CN1559523A (en) | Naodesheng soft capsule and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Zanhui Document name: Written notice of preliminary examination of application for patent for invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Zanhui Document name: Second notice of examination advice |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hunan Tianjin Pharmaceutical Co., Ltd. Assignor: Liu Zanhui Contract record no.: 2011430000137 Denomination of invention: Quality control of Chinese medicinal compound preparation Granted publication date: 20090729 License type: Exclusive License Open date: 20061227 Record date: 20110815 |
|
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 410000, 1 Furong new 489, three middle Furong Road, Hunan, Changsha Province, room 1, unit 1505 Patentee after: Liu Zanhui Address before: 410000 human resources department, Hunan switch factory, 70 academy road, Changsha, Hunan Patentee before: Liu Zanhui |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090729 Termination date: 20120530 |